Accessing Venture Capital to Strengthen Philadelphia’s Life Science Ecosystem

Like many other markets from coast to coast, Philadelphia is looking to tackle a VC shortage to ensure the health and longevity of its life sciences ecosystem. Not only would an infusion of cash help unleash greater deal flow, but it would greatly help the area secure and retain life science and biotech organizations looking for market environments conducive to growth.

In today’s economic climate, life science and biotech firms are seeking out affordable markets ripe with funding opportunities that can take them through all growth stages. While public sector support will play an important role in backing life sciences growth, a holistic approach is needed to ignite a substantial deployment of capital.

Join Builds Bio+ in Philadelphia for a timely breakfast program discussing strategies to attract VC and angel investors and secure equity and capital that allow startups to mature and flourish in the Philadelphia region.

Life science and investment experts will share critical insights on:

• Securing funding opportunities for home-grown startups
• Aligning public and private interests to attract investors
• Preventing relocations to support full cycle maturity

Resources Related to Philadelphia’s Need for a Capital Infusion:

• Philadelphia Magazine, May 2023, Philly’s Biotech Scene Needs More Local Money – Now